Epstein Barr Virus Market By Test (Complete Blood Count Test, Monospot test and Others), By Application (Mononucleosis, Gastric Carcinoma, Multiple Sclerosis and Others), and By Region - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI472921 | Publish Date: May 2024 | No. of Pages: 168

Global Epstein Barr Virus Market Companies

  • Bbott
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Cardinal Health Inc.
  • Thermo Fischer Scientific Inc.

Recent News:

  • In May 2022, The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV). EBV is the primary cause of infectious mononucleosis and is associated with certain cancers and autoimmune diseases. The Phase 1 study, which will be conducted at the NIH Clinical Center in Bethesda, Maryland, is one of only two studies to test an investigational EBV vaccine in more than a decade.